← All news

FROM THE NEWS FEED

Q4’25 Psychedelic Lobbying Update

2026-02-13 • Psychedelic Alpha

Article summary

Each quarter, we provide a look at federal lobbying disclosures by psychedelic drug developers and nonprofits. Here, we share our analysis of the latest developments for our Pα+ subscribers.

Continue to the original publication for the complete article.